Epilepsies, Partial
58
4
6
43
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
17 trials with published results (29%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.2%
3 terminated out of 58 trials
93.5%
+7.0% vs benchmark
41%
24 trials in Phase 3/4
40%
17 of 43 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 43 completed trials
Clinical Trials (58)
Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures
Transcranial Direct Current to Treat Epilepsy at Home
Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)
Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies
High-resolution Multi-parametric Magnetic Resonance Imaging for Focal Epilepsy
Thermocoagulation in Drug Resistant Focal Epilepsy
Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study
Treating Postictal Symptoms Using Ibuprofen and Nifedipine
Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy
Effects of Diazepam on RNS Detections
Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)
Open-label Extension to Protocol 1042-0600
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy
Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept
Novel Network Analysis of Intracranial Stereoelectroencephalography
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures